Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  calcium carbonate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 28 for your search:
Start Over
Vitamin D/Calcium Polyp Prevention Study
Phase: Phase III, Phase II
Type: Prevention
Status: Closed
Age: 45 to 75
Sponsor: NCI, Other
Protocol IDs: 5 R01 CA098286-03, 5R01CA098286-10, NCT00153816
Phase III Randomized Study of Zoledronate in Patients With Bone Metastases Secondary to Prostate Cancer (Summary Last Modified 12/1999)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NOVARTIS-4244603039
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068781, U10CA031946, CALGB-79809, NCI-P01-0184, NCT00022087
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069502, NCCTG-N01C8, NCI-P02-0229, N01C8, NCT00043069
Phase III Hormone Therapy with FXM Plus Calcium Carbonate/Vitamin D and Calcitonin for Recurrent Breast Carcinoma with Osseous Metastases
Phase: Phase III
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: CBCG-4400
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N02C1, NCI-2012-02515, CDR0000270449, N02C1, NCT00054418
Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 40 to 55
Sponsor: Other
Protocol IDs: 1769-03-A, CZOL446E, NCT00202059
A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: BONEII, NCT00186901
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0518, CDR0000476469, NCI-2009-00884, 0518, NCT00329797
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0517, CDR0000491233, NCI-2009-00727, NCT00365105
A Study of Actonel for the Prevention of Bone Loss
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: ID03-0124, NCI-2010-01997, NCT00452439
Women's Health Initiative (WHI)
Phase: Phase III
Type: Health services research, Natural history/Epidemiology, Prevention
Status: Completed
Age: 50 to 79
Sponsor: NCI, NHLBI
Protocol IDs: 114, NCT00000611
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27
Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: MA27B, CAN-NCIC-MA27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, CDR0000483099, NCIC-MA.27B, NCT00354302
Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OXALI_L_03768, U1111-1116-9494, NCT01087658
Phase II Chemoprevention Study of Vitamin D3 and Calcium for Colorectal Cancer (Summary Last Modified 01/98)
Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CPMC-IRB-6850, NCI-P97-0109
Calcium and Vitamin D vs Markers of Adenomatous Polyps
Phase: Phase II
Type: Prevention
Status: Completed
Age: 30 to 74
Sponsor: NCI, Other
Protocol IDs: 0126-2004, R01CA104637, NCT00208793
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005NT018, UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, UMN-2005NT018, NCT00321932
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
Phase: Phase II
Type: Natural history/Epidemiology, Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 6346, NCI-2010-00621, UWCC-6346, NOVARTIS-UWCC-6346, UWCC-06-2386-H/A, FHCRC-6346, NCT00416715
Phase I Study of Two Calcium Compounds in Patients with Previously Resected Dukes' Stages A/B/C Adenocarcinoma of the Colon (Summary Last Modified 03/93)
Phase: Phase I
Type: Prevention
Status: Closed
Age: 30 to 80
Sponsor:
Protocol IDs: MDA-DM-90046, NCI-P93-0036
Effect of Vitamin D and Calcium on Genes in the Colon
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 48 to 72
Sponsor: Other
Protocol IDs: RUH IRB # PHO-0554, NCT00298545
Hormonal Therapy with Fluoxymesterone plus Salmon Calcitonin for Breast Cancer Metastatic to Bone and Soft Tissue
Phase: No phase specified
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: CBCG-4401
Pilot Randomized Study of Calcium for Chemoprevention of Colorectal Adenomas and New Primary Carcinomas in Surgically Treated Patients
Phase: No phase specified
Type: Prevention
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: SWOG-9041, NCI-P92-0031
Start Over